Change Healthcare (CHNG) 10-Q 3 Feb 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2021	Jan. 24, 2022
Document Type	10-Q
Document Quarterly Report	true
Current Fiscal Year End Date	--03-31
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2022
Document Transition Report	false
Entity File Number	001-38961
Entity Registrant Name	Change Healthcare Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-2152098
Entity Address, Address Line One	424 Church Street
Entity Address, Address Line Two	Suite 1400
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37219
City Area Code	615
Local Phone Number	932-3000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		311,895,569
Amendment Flag	false
Entity Central Index Key	0001756497
Document Fiscal Period Focus	Q3
Common Stock [Member]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	CHNG
Security Exchange Name	NASDAQ
Tangible Equity Units [Member]
Title of 12(b) Security	6.00% Tangible Equity Units
Trading Symbol	CHNGU
Security Exchange Name	NASDAQ

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Total revenue	$ 866,065	$ 785,141	$ 2,560,684	$ 2,235,261
Operating expenses
Cost of operations (exclusive of depreciation and amortization below)	354,107	332,373	1,052,802	977,568
Research and development	67,314	58,323	205,624	168,110
Sales, marketing, general and administrative	187,275	161,959	548,272	499,039
Customer postage	54,917	49,877	158,675	145,672
Depreciation and amortization	170,782	151,143	502,463	436,552
Accretion and changes in estimate with related parties, net	2,960	956	8,867	10,414
Gain on sale of businesses		(32,217)		(60,487)
Total operating expenses	837,355	722,414	2,476,703	2,176,868
Operating income (loss)	28,710	62,727	83,981	58,393
Non-operating (income) expense
Interest expense, net	58,433	61,439	177,284	185,733
Loss on extinguishment of debt	1,653	6,145	3,885	7,634
Other, net	3,211	(2,491)	2,605	(4,443)
Total non-operating (income) expense	63,297	65,093	183,774	188,924
Income (loss) before income tax provision (benefit)	(34,587)	(2,366)	(99,793)	(130,531)
Income tax provision (benefit)	(10,115)	(4,562)	(35,313)	(31,411)
Net income (loss)	$ (24,472)	$ 2,196	$ (64,480)	$ (99,120)
Net income (loss) per share:
Basic	$ (0.08)	$ 0.01	$ (0.20)	$ (0.31)
Diluted	$ (0.08)	$ 0.01	$ (0.20)	$ (0.31)
Weighted average common shares outstanding:
Basic	324,381,353	321,013,595	323,668,343	320,570,092
Diluted	324,381,353	324,815,524	323,668,343	320,570,092
Solutions [Member]
Total revenue	$ 811,148	$ 735,264	$ 2,402,009	$ 2,089,589
Postage [Member]
Total revenue	$ 54,917	$ 49,877	$ 158,675	$ 145,672

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Net income (loss)	$ (24,472)	$ 2,196	$ (64,480)	$ (99,120)
Other comprehensive income (loss):
Foreign currency translation adjustment	3,693	11,526	5,108	23,100
Changes in fair value of interest rate caps, net of taxes	4,595	(81)	4,755	(6,261)
Other comprehensive income (loss)	8,288	11,445	9,863	16,839
Total comprehensive income (loss)	$ (16,184)	$ 13,641	$ (54,617)	$ (82,281)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Mar. 31, 2021
Current assets:
Cash & cash equivalents	$ 96,011	$ 113,101
Accounts receivable, net	781,530	732,614
Contract assets, net	126,487	132,856
Prepaid expenses and other current assets	149,234	140,258
Total current assets	1,153,262	1,118,829
Property and equipment, net	144,179	174,370
Operating lease right-of-use assets, net	72,374	93,412
Goodwill	4,114,682	4,108,792
Intangible assets, net	3,821,383	4,187,072
Other noncurrent assets, net	542,100	430,141
Total assets	9,847,980	10,112,616
Current liabilities:
Accounts payable	87,477	57,449
Accrued expenses	473,470	484,293
Deferred revenue	431,239	436,666
Due to related parties, net	11,392	10,766
Current portion of long-term debt	15,009	27,339
Current portion of operating lease liabilities	24,513	30,608
Total current liabilities	1,043,100	1,047,121
Long-term debt, excluding current portion	4,572,865	4,734,775
Long-term operating lease liabilities	56,956	75,396
Deferred income tax liabilities	563,828	605,291
Tax receivable agreement obligations due to related parties	100,565	103,151
Tax receivable agreement obligations	198,210	229,082
Other long-term liabilities	64,861	65,572
Total liabilities	6,600,385	6,860,388
Commitments and contingencies
Stockholders' Equity
Common Stock (par value, $0.001), 9,000,000,000 and 9,000,000,000 shares authorized and 311,716,514 and 306,796,076 shares issued and outstanding at December 31, 2021 and March 31, 2021, respectively	312	307
Preferred stock (par value, $0.001), 900,000,000 shares authorized and no shares issued and outstanding at both December 31, 2021 and March 31, 2021
Additional paid-in capital	4,333,371	4,283,391
Accumulated other comprehensive income (loss)	21,084	11,221
Accumulated deficit	(1,107,172)	(1,042,691)
Total stockholders' equity	3,247,595	3,252,228
Total liabilities and stockholders' equity	$ 9,847,980	$ 10,112,616

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2021	Mar. 31, 2021
Consolidated Balance Sheets [Abstract]
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	9,000,000,000	9,000,000,000
Common Stock, shares issued	311,716,514	306,796,076
Common Stock, shares outstanding	311,716,514	306,796,076
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	900,000,000	900,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Total
Balance (ASU 2016-13 [Member]) at Mar. 31, 2020			$ (417)			$ (417)
Balance at Mar. 31, 2020	$ 303	$ 4,222,580		$ (930,064)	$ (7,372)		$ 3,285,447
Balance, shares at Mar. 31, 2020	303,428,142
Equity compensation expense		8,780					8,780
Issuance of common stock under equity compensation plans	$ 1	2,143					2,144
Issuance of common stock under equity compensation plans, shares	341,230
Net income (loss)				(58,694)			(58,694)
Foreign currency translation adjustment					6,353		6,353
Change in fair value of interest rate caps, net of taxes					(4,184)		(4,184)
Other		(75)					(75)
Balance at Jun. 30, 2020	$ 304	4,233,428		(989,175)	(5,203)		3,239,354
Balance, shares at Jun. 30, 2020	303,769,372
Balance (ASU 2016-13 [Member]) at Mar. 31, 2020			$ (417)			$ (417)
Balance at Mar. 31, 2020	$ 303	4,222,580		(930,064)	(7,372)		3,285,447
Balance, shares at Mar. 31, 2020	303,428,142
Net income (loss)							(99,120)
Foreign currency translation adjustment							23,100
Change in fair value of interest rate caps, net of taxes							(6,261)
Balance at Dec. 31, 2020	$ 305	4,253,567		(1,029,601)	9,467		3,233,738
Balance, shares at Dec. 31, 2020	304,656,863
Balance at Jun. 30, 2020	$ 304	4,233,428		(989,175)	(5,203)		3,239,354
Balance, shares at Jun. 30, 2020	303,769,372
Equity compensation expense		12,372					12,372
Issuance of common stock under equity compensation plans		408					408
Issuance of common stock under equity compensation plans, shares	911,961
Employee tax withholding on vesting of equity compensation awards		(3,131)					(3,131)
Employee tax withholding on vesting of equity compensation awards, shares	(254,764)
Net income (loss)				(42,622)			(42,622)
Foreign currency translation adjustment					5,221		5,221
Change in fair value of interest rate caps, net of taxes					(1,996)		(1,996)
Other		(356)					(356)
Balance at Sep. 30, 2020	$ 304	4,242,721		(1,031,797)	(1,978)		3,209,250
Balance, shares at Sep. 30, 2020	304,426,569
Equity compensation expense		9,673					9,673
Issuance of common stock under equity compensation plans	$ 1	1,606					1,607
Issuance of common stock under equity compensation plans, shares	249,288
Employee tax withholding on vesting of equity compensation awards		(294)					(294)
Employee tax withholding on vesting of equity compensation awards, shares	(18,994)
Net income (loss)				2,196			2,196
Foreign currency translation adjustment					11,526		11,526
Change in fair value of interest rate caps, net of taxes					(81)		(81)
Other		(139)					(139)
Balance at Dec. 31, 2020	$ 305	4,253,567		(1,029,601)	9,467		3,233,738
Balance, shares at Dec. 31, 2020	304,656,863
Balance at Mar. 31, 2021	$ 307	4,283,391		(1,042,691)	11,221		3,252,228
Balance, shares at Mar. 31, 2021	306,796,076
Equity compensation expense		23,191					23,191
Issuance of common stock under equity compensation plans	$ 2	1,443					1,445
Issuance of common stock under equity compensation plans, shares	1,948,163
Employee tax withholding on vesting of equity compensation awards	$ (1)	(13,015)					(13,016)
Employee tax withholding on vesting of equity compensation awards, shares	(564,116)
Net income (loss)				(3,605)			(3,605)
Foreign currency translation adjustment					3,571		3,571
Change in fair value of interest rate caps, net of taxes					119		119
Conversion of tangible equity units	$ 3	(3)
Conversion of tangible equity units, shares	2,497,813
Other		(80)					(80)
Balance at Jun. 30, 2021	$ 311	4,294,927		(1,046,296)	14,911		3,263,853
Balance, shares at Jun. 30, 2021	310,677,936
Balance at Mar. 31, 2021	$ 307	4,283,391		(1,042,691)	11,221		3,252,228
Balance, shares at Mar. 31, 2021	306,796,076
Net income (loss)							(64,480)
Foreign currency translation adjustment							5,108
Change in fair value of interest rate caps, net of taxes							4,755
Balance at Dec. 31, 2021	$ 312	4,333,371		(1,107,172)	21,084		3,247,595
Balance, shares at Dec. 31, 2021	311,716,514
Balance at Jun. 30, 2021	$ 311	4,294,927		(1,046,296)	14,911		3,263,853
Balance, shares at Jun. 30, 2021	310,677,936
Equity compensation expense		23,776					23,776
Issuance of common stock under equity compensation plans		1,031					1,031
Issuance of common stock under equity compensation plans, shares	896,107
Employee tax withholding on vesting of equity compensation awards		(5,985)					(5,985)
Employee tax withholding on vesting of equity compensation awards, shares	(262,835)
Net income (loss)				(36,404)			(36,404)
Foreign currency translation adjustment					(2,156)		(2,156)
Change in fair value of interest rate caps, net of taxes					41		41
Other		10					10
Balance at Sep. 30, 2021	$ 311	4,313,759		(1,082,700)	12,796		3,244,166
Balance, shares at Sep. 30, 2021	311,311,208
Equity compensation expense		22,899					22,899
Issuance of common stock under equity compensation plans	$ 1	1,226					1,227
Issuance of common stock under equity compensation plans, shares	620,025
Employee tax withholding on vesting of equity compensation awards		(4,320)					(4,320)
Employee tax withholding on vesting of equity compensation awards, shares	(214,719)
Net income (loss)				(24,472)			(24,472)
Foreign currency translation adjustment					3,693		3,693
Change in fair value of interest rate caps, net of taxes					4,595		4,595
Other		(193)					(193)
Balance at Dec. 31, 2021	$ 312	$ 4,333,371		$ (1,107,172)	$ 21,084		$ 3,247,595
Balance, shares at Dec. 31, 2021	311,716,514

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (24,472)	$ (3,605)	$ 2,196	$ (58,694)	$ (64,480)	$ (99,120)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	170,782		151,143		502,463	436,552
Amortization of capitalized software developed for sale	935		460		2,510	550
Accretion and changes in estimate, net	4,482		(2,759)		13,570	8,429
Equity compensation					74,718	34,858
Deferred income tax expense (benefit)					(41,357)	(33,905)
Amortization of debt discount and issuance costs					23,563	24,587
Loss on extinguishment of debt	1,653		6,145		3,885	7,634
Non-cash lease expense					20,440	21,930
Gain on sale of businesses			(32,217)			(60,487)
Other, net					14,235	4,681
Changes in operating assets and liabilities:
Accounts receivable, net					(49,081)	28,331
Contract assets, net					8,118	5,201
Prepaid expenses and other assets					(50,602)	(69,609)
Accounts payable					24,008	(15,785)
Accrued expenses and other liabilities					(37,159)	68,708
Deferred revenue					(6,039)	124,679
Net cash provided by (used in) operating activities					438,792	487,234
Cash flows from investing activities:
Capitalized expenditures					(192,629)	(182,929)
Acquisitions, net of cash acquired						(439,483)
Proceeds from sale of businesses						117,124
Other, net					(662)	1,100
Net cash provided by (used in) investing activities					(193,291)	(504,188)
Cash flows from financing activities:
Payments on Term Loan Facility					(180,000)	(265,000)
Payments under tax receivable agreements					(21,537)	(20,691)
Receipts (payments) on derivative instruments					(22,255)	(22,255)
Employee tax withholding on vesting of equity compensation awards					(23,320)	(3,425)
Payments on deferred financing obligations					(10,125)	(9,081)
Payment of senior amortizing notes					(12,188)	(11,599)
Proceeds from exercise of equity awards					6,812	4,158
Payments on Revolving Facility						(250,000)
Proceeds from issuance of Senior Notes						325,000
Other, net					(310)	(6,650)
Net cash provided by (used in) financing activities					(262,923)	(259,543)
Effect of exchange rate changes on cash and cash equivalents					332	3,449
Net increase (decrease) in cash and cash equivalents					(17,090)	(273,048)
Cash and cash equivalents at beginning of period		$ 113,101		$ 410,405	113,101	410,405	$ 410,405
Cash and cash equivalents at end of period	$ 96,011		$ 137,357		$ 96,011	$ 137,357	$ 113,101

Nature of Business and Organiza

Nature of Business and Organization	9 Months Ended
	Dec. 31, 2021
Nature of Business and Organization [Abstract]
Nature of Business and Organization	1. Nature of Business and Organization Change Healthcare Inc. (the “Company”, “our” or “we”) is an independent healthcare technology company, focused on accelerating the transformation of the healthcare system through the power of our healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system. Our platform and comprehensive suite of software, analytics, technology-enabled services and network solutions drive improved results in the complex workflows of healthcare system payers and providers by enhancing clinical decision making, simplifying billing, collection and payment processes, and enabling a better patient experience.We are a Delaware corporation originally formed on June 22, 2016, to initially hold an equity investment in Change Healthcare LLC (the “Joint Venture”), a joint venture between the Company and McKesson Corporation (“McKesson”). Effective July 1, 2019, we completed our initial public offering. The proceeds from the common stock offering were subsequently contributed to the Joint Venture in exchange for additional units of the Joint Venture, which together with the Company’s existing holdings represented an approximate 41% interest in the Joint Venture. On March 10, 2020, McKesson completed a split-off of its interest in the Joint Venture through an exchange offer of its common stock for shares of PF2 SpinCo, Inc, a Delaware corporation and wholly owned subsidiary of McKesson (“SpinCo”). Immediately following consummation of the exchange offer, SpinCo was merged with and into Change Healthcare Inc. (the “Merger”). Subsequent to the Merger, we own 100% of Change Healthcare LLC, and as a result, consolidate the financial statements of Change Healthcare LLC.UnitedHealth Group Incorporated On January 5, 2021, we entered into an Agreement and Plan of Merger (the “UHG Agreement”) with UnitedHealth Group Incorporated (“UnitedHealth Group”), and UnitedHealth Group’s wholly owned subsidiary Cambridge Merger Sub Inc. Pursuant to the UHG Agreement, UnitedHealth Group has agreed to acquire all of the outstanding shares of the Company’s common stock for $25.75 per share in cash (the “UHG Transaction”). On April 13, 2021, our stockholders approved a proposal to adopt the UHG Agreement, thereby satisfying one of the closing conditions contained in the UHG Agreement. The consummation of the transaction remains subject to the satisfaction or, to the extent permitted by law, waiver of other customary closing conditions.The UHG Agreement contains representations, warranties, covenants, closing conditions and termination rights customary for transactions of this type. Until the earlier of the termination of the UHG Agreement and the consummation of the UHG Transaction, we have agreed to operate our business in the ordinary course and have agreed to certain other operating covenants, as set forth in the UHG Agreement. On March 24, 2021, the Company and UnitedHealth Group each received a request for additional information and documentary materials (collectively, the “Second Request”) from the U.S. Department of Justice (the “DOJ”) in connection with the DOJ’s review of the UHG Transaction. The effect of the Second Request is to extend the waiting period imposed under the HSR Act until the 30th day after substantial compliance by the Company and UnitedHealth Group with the Second Request (or such other date upon which substantial compliance is considered effective), unless the waiting period is terminated earlier by the DOJ or extended by the parties to the UHG Transaction. On August 7, 2021, the parties entered into a timing agreement (the “Timing Agreement”) with the DOJ pursuant to which they agreed not to consummate the UHG Transaction before 120 days following the date on which both parties certified substantial compliance with the Second Request.Both the Company and UnitedHealth Group have now certified substantial compliance with the Second Request. On November 1, 2021, the Company and UnitedHealth Group entered into an amendment to the Timing Agreement with the DOJ pursuant to which they agreed not to consummate the UHG Transaction before 12:01 a.m. Eastern Time on February 22, 2022, unless they have received written notice from the DOJ prior to such date that the DOJ has closed its investigation. The parties have been working cooperatively with the DOJ and will continue to do so.On December 9, 2021, UnitedHealth Group delivered written notice to the Company that it was exercising its unilateral right to extend the Outside Date (as defined in the UHG Agreement) to April 5, 2022, in accordance with Section 9.2(a) of the UHG Agreement. COVID-19 ConsiderationsOn March 11, 2020, the World Health Organization declared the coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the U.S., federal, state and local governments imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures led to weakened conditions in many sectors of the economy, including a decline in healthcare transaction volumes that are integral to our business.In calendar year 2021, the global economy began reopening and wider distribution of vaccines will likely continue to encourage greater economic activity. Nevertheless, we are unable to predict how widely the vaccines will be utilized, whether they will be effective in preventing the spread of COVID-19 (including its variant strains), and the extent to which our business, results of operations, financial condition or liquidity will ultimately be impacted by COVID-19. However, we are not presently aware of events or circumstances arising from COVID-19 that would require us to revise the carrying value of our assets or liabilities, nor do we expect the impact of COVID-19 to cause us to be unable to comply with our debt covenants or meet our contractual obligations.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Dec. 31, 2021
Significant Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting PoliciesBasis of Presentation The unaudited consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”) Guidelines, Rules and Regulations and, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of results for the unaudited interim periods presented. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted. The results of operations for the interim period are not necessarily indicative of the results to be obtained for the full fiscal year. All intercompany accounts and transactions have been eliminated upon consolidation in the unaudited consolidated financial statements.RevenueWe recognize revenue at an amount that reflects the consideration we expect to be entitled to in exchange for transferring goods or services to a customer, in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). See Note 3, Revenue Recognition, for additional information.Equity Compensation We measure stock-based compensation cost based on the estimated fair value of the award on the grant date and recognize the expense over the requisite service period, typically on a straight-line basis. We recognize stock-based compensation expense for awards with performance conditions if and when we conclude that it is probable that the performance conditions will be achieved. The fair value of equity awards is recognized as expense in the same period and in the same manner as if we had paid cash for the goods or services. Forfeitures are recognized as they occur. We issue new shares of common stock upon vesting of equity awards and upon exercise of vested options. We do not intend to repurchase any issued shares of common stock. During the three months ended December 31, 2021 and 2020 we recognized $24,807 and $10,944 of equity compensation expense, respectively. During the nine months ended December 31, 2021 and 2020 we recognized $74,718 and $34,858 of equity compensation expense, respectively. At December 31, 2021, aggregate unrecognized compensation expense related to outstanding awards was $197,183.Upon closing of the UHG Transaction, existing awards will generally convert to equivalent UHG awards with consistent vesting provisions. Certain awards will vest upon closing of the UHG Transaction per the terms of the UHG Agreement. Allowance for Credit LossesThe allowance for credit losses of $23,370 and $24,126 at December 31, 2021 and March 31, 2021, respectively, was primarily based on historical credit loss experience, current conditions, future expected credit losses, and adjustments for certain asset-specific risk characteristics. The following table summarizes activity related to the allowance for credit losses: Nine Months Ended December 31, 2021 2020Balance at beginning of period $ 24,126 $ 22,360Cumulative effect of accounting change-ASU 2016-13 — 417Acquisitions and Dispositions (1) — (3,534)Provisions 6,084 11,623Write-offs (6,840) (6,863)Balance at end of period $ 23,370 $ 24,003 (1)For the nine months ended December 31, 2020, this amount relates primarily to the sale of Connected Analytics and Capacity Management. Recently Adopted Accounting Pronouncements London Interbank Offered Rate (LIBOR) Reform In March 2020, the FASB issued ASU No. 2020-04, as amended by ASU No. 2021-01, which created Topic 848 – Reference Rate Reform. ASU No. 2020-04 contains optional practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts which may be elected over time as activities occur. Among other things, the ASU intends to ease the transition from LIBOR to an alternative reference rate. During the first quarter of fiscal year 2021, we elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. We continue to evaluate the impacts of ASU No. 2020-04 and may apply other elections as reference rate reform activities progress. Accounting Pronouncements Not Yet Adopted Derivatives and Convertible InstrumentsIn August 2020, the FASB issued ASU No. 2020-06 which simplifies the accounting for convertible instruments and amends the guidance addressing the derivatives scope exception for contracts in an entity’s own equity. The standard is scheduled to be effective for us beginning April 1, 2022. Given the forward purchase contracts of our Tangible Equity Units (“TEUs”) qualify for the derivatives scope exception and are currently accounted for under that guidance, we do not expect a material impact upon adoption. We will continue to evaluate the impact of this pronouncement prior to adoption.Contract Assets and Liabilities from Contracts with CustomersIn October 2021, the FASB issued ASU No. 2021-08 which improves the accounting for revenue contracts with customers acquired in a business combination by addressing diversity in practice and requiring the acquirer to measure contract assets and liabilities acquired in accordance with ASC 606. The standard is scheduled to be effective for us beginning April 1, 2023, with early adoption permitted. Once adopted, the updated guidance could potentially have a material impact on the amount of assets, liabilities, and revenue recognized from acquired businesses, depending on the size and nature of those transactions.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Dec. 31, 2021
Revenue Recognition [Abstract]
Revenue Recognition	3. Revenue RecognitionWe generate most of our solutions revenue using technology solutions (generally Software as a Service (“SaaS”)) to provide services to our customers that automate and simplify business and administrative functions for payers, providers, pharmacies, and channel partners and through the licensing of software, software systems (consisting of software, hardware and maintenance support) and content. We recognize revenue when the customer obtains control of the good or service through satisfying a performance obligation by transferring the promised good or service to the customer. Contract Balances As of December 31, 2021, we expect 95% of the deferred revenue balance to be recognized in one year or less. Approximately $365,086 of the balance at the beginning of fiscal year 2022 was recognized during the nine months ended December 31, 2021. Approximately $245,760 of the balance at the beginning of fiscal year 2021 was recognized during the nine months ended December 31, 2020.Remaining Performance Obligations The aggregate amount of transaction price allocated to performance obligations that are unsatisfied (or partially unsatisfied) for executed contracts includes deferred revenue and other revenue yet to be recognized from non-cancellable contracts. As of December 31, 2021, remaining performance obligations totaled $1,349,496, of which 51% is expected to be recognized over the next 12 months, and the remaining 49% thereafter.In this balance, we do not include the value of unsatisfied performance obligations related to those contracts for which we recognize revenue at the amount for which we have the right to invoice for services performed. Additionally, this balance does not include revenue related to performance obligations that are part of a contract with an original expected duration of one year or less. Lastly, this balance does not include variable consideration allocated to the individual goods or services in a series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer. Examples includes variable fees associated with transaction processing and contingent fee services. Disaggregated RevenueWe disaggregate the revenue from contracts with customers by operating segment as we believe doing so best depicts how the nature, amount, timing and uncertainty of revenues are affected by economic factors. See Note 16, Segment Reporting, for total revenue disaggregated by operating segment for the three and nine months ended December 31, 2021 and 2020. In addition to disaggregating revenue by operating segment, we disaggregate between revenue that is recognized over time and revenue that is recognized at a point in time. For the three and nine months ended December 31, 2021, 97% and 96% of revenue was recognized over time, respectively, and 3% and 4% of revenue was recognized at a point in time, respectively. For the three and nine months ended December 31, 2020, 98% and 96% of revenue was recognized over time, respectively, and 2% and 4% of revenue was recognized at a point in time, respectively.

Business Combinations

Business Combinations	9 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Business Combinations	4. Business CombinationsFiscal Year 2021 Transactions eRx Network Holdings, Inc. On May 1, 2020, we exercised our option to purchase and completed the acquisition of 100% of the ownership interest in eRx Network Holdings, Inc. (“eRx”), a leading provider in comprehensive, innovative and secure data-driven solutions for pharmacies. At the time of the acquisition, all outstanding eRx equity awards were canceled and holders of eRx stock options and vested eRx stock appreciation rights were able to elect to receive consideration in the form of a cash payment or vested stock appreciation rights of the Company. Prior to the acquisition, we held an option to purchase eRx which we accounted for as an equity investment. Therefore, our acquisition of eRx was accounted for as a business combination achieved in stages under the acquisition method in accordance with Accounting Standards Codification 805, Business Combinations (“ASC 805”). Accordingly, at the acquisition, we remeasured our business purchase option to fair value and recognized a loss of $6,000 which is recorded in Other, net on our consolidated statement of operations for the nine months ended December 31, 2020. The following table summarizes information related to this acquisition as of the acquisition date. The fair values of the assets acquired and the liabilities assumed were determined based on information available to the Company using primarily an income-based approach. We consider our accounting for the assets acquired and liabilities assumed in the eRx acquisition to be complete. eRxCash paid at closing$ 249,359Fair value of eRx purchase option 140,500Fair value of vested stock appreciation rights 5,097Cash paid for canceled eRx equity awards 5,891Total Consideration Fair Value at Acquisition Date$ 400,847 Allocation of the Consideration Transferred: Cash$ 54,108Accounts receivable 12,747Prepaid expenses and other current assets 609Goodwill 225,156Identifiable intangible assets: Customer relationships (life 17 years) 131,200Technology-based intangible assets (life 9-12 years) 29,700Other noncurrent assets 20Accounts payable (2,543)Accrued expenses and other current liabilities (10,933)Deferred income tax liabilities (39,217)Total consideration transferred$ 400,847The goodwill recognized, all of which is assigned to the Network Solutions segment, is primarily attributable to expected synergies of the combined businesses and the acquisition of an assembled workforce knowledgeable of the healthcare and information technology industries. The goodwill is not expected to be deductible for tax purposes. See Note 6, Goodwill. Acquisition costs related to the purchase of eRx were not material. PDX, Inc. On June 1, 2020, we completed the cash purchase of 100% of the ownership interest in PDX, Inc. (“PDX”), a company focused on delivering patient-centric and innovative technologies for pharmacies and health systems. We accounted for this transaction as a business combination using the acquisition method. The fair values of the assets acquired and the liabilities assumed were determined based on information available to the Company using primarily an income-based approach. We consider our accounting for the assets acquired and liabilities assumed in the PDX acquisition to be complete. After customary working capital adjustments, transaction fees and other adjustments, the total consideration fair value at the acquisition date was $198,291. The following table summarizes the allocation of consideration transferred: PDXCash$ 755Accounts receivable 5,739Prepaid expenses and other current assets 2,251Property and equipment 840Goodwill 98,830Identifiable intangible assets: Customer relationships (life 18 years) 74,300Technology-based intangible assets (life 10-11 years) 25,300Other noncurrent assets 690Accounts payable (3,882)Deferred revenue, current (2,946)Accrued expenses and other current liabilities (3,364)Other long-term liabilities (222)Total consideration transferred$ 198,291 The goodwill recognized, all of which is assigned to the Network Solutions segment, is primarily attributable to expected synergies of the combined businesses and the acquisition of an assembled workforce knowledgeable of the healthcare and information technology industries. The goodwill is expected to be deductible for tax purposes. See Note 6, Goodwill. Acquisition costs related to the purchase of PDX were not material.

Dispositions

Dispositions	9 Months Ended
	Dec. 31, 2021
Dispositions [Abstract]
Dispositions	5. DispositionsConnected Analytics On May 1, 2020, we completed the sale of our Connected Analytics business, which was included in our Software and Analytics segment, for total consideration of $55,000, subject to a customary working capital adjustment, including a $25,000 note receivable from the buyer which was recorded within Other noncurrent assets, net on the consolidated balance sheet at June 30, 2020. The net book value of the Connected Analytics business prior to the sale was $23,428, which includes primarily net accounts receivable of $16,636, goodwill of $21,705 and deferred revenue of $17,083. In connection with this transaction, we recognized a pre-tax gain on disposal of $24,337 during the year ended March 31, 2021, which was included within Gain on sale of businesses on the consolidated statement of operations. In July 2020, we received $25,000 plus interest from the buyer in satisfaction of the outstanding note receivable.Capacity ManagementOn December 2, 2020, we completed the sale of our Capacity Management business, which was included in our Software and Analytics segment, for total consideration of $67,500, subject to a customary working capital adjustment. The net book value of the Capacity Management business prior to the sale was $31,690, which includes primarily net accounts receivable of $14,991, goodwill of $26,944 and deferred revenue of $15,230. In connection with this transaction, we recognized a pre-tax gain on disposal of $31,690 during the year ended March 31, 2021.

Goodwill

Goodwill	9 Months Ended
	Dec. 31, 2021
Goodwill [Abstract]
Goodwill	6. Goodwill The following table presents the changes in the carrying amount of goodwill:ssss Software and Analytics Network Solutions Technology-Enabled Services TotalBalance at March 31, 2021 $ 1,758,302 $ 1,970,739 $ 379,752 $ 4,108,792Acquisitions — — — —Dispositions — — — —Effects of foreign currency 6,032 — — 6,032Adjustments (142) — — (142)Balance at December 31, 2021 $ 1,764,192 $ 1,970,739 $ 379,752 $ 4,114,682

Long-Term Debt

Long-Term Debt	9 Months Ended
	Dec. 31, 2021
Long-Term Debt [Abstract]
Long-Term Debt	7. Long-Term DebtLong-term debt consists of the following: December 31, 2021 March 31, 2021Senior Credit Facilities $5,100,000 Term Loan Facility, due March 1, 2024, net of unamortized discount of $62,695 and $87,698 at December 31, 2021 and March 31, 2021, respectively (effective interest rate of 4.42% and 4.42%, respectively) $ 3,250,555 $ 3,405,552$785,000 Revolving Facility, expiring July 3, 2024, and bearing interest at a variable interest rate — —Senior Notes $1,325,000 5.75% Senior Notes due March 1, 2025, net of unamortized discount of $5,716 and $6,921 at December 31, 2021 and March 31, 2021, respectively (effective interest rate of 5.90% and 5.90%, respectively) 1,319,284 1,318,079Tangible Equity Unit Senior Amortizing Note $47,367 Senior Amortizing Notes due June 30, 2022, net of unamortized discount of $60 and $293 at December 31, 2021 and March 31, 2021, respectively (effective interest rate of 7.44% and 7.44%, respectively) 8,390 20,345Other 9,645 18,138Less current portion (15,009) (27,339)Long-term debt, excluding current portion $ 4,572,865 $ 4,734,775 Our long-term indebtedness includes a senior secured term loan facility (the “Term Loan Facility”) and a revolving credit facility (the “Revolving Facility”; together with the Term Loan Facility, the “Senior Credit Facilities”). The Senior Credit Facilities provide us with the right at any time to request additional term loan tranches and/or term loan increases, increases in the revolving commitments and/or additional revolving credit facilities. Our long-term indebtedness also includes 5.75% senior notes due March 1, 2025 (the “Senior Notes”) with interest payable semi-annually on March 1 and September 1 of each year.As of December 31, 2021, we were in compliance with all of the applicable covenants under the Senior Credit Facilities and the Senior Notes. In the third quarter of fiscal year 2022, we repaid $80,000 on our Term Loan Facility and recognized a loss on extinguishment of $1,653 in our consolidated statement of operations.

Interest Rate Cap Agreements

Interest Rate Cap Agreements	9 Months Ended
	Dec. 31, 2021
Interest Rate Cap Agreements [Abstract]
Interest Rate Cap Agreements	8. Interest Rate Cap AgreementsRisk Management Objective of Using DerivativesWe are exposed to certain risks arising from both our business operations and economic conditions. We principally manage exposures to a wide variety of business and operational risks through management of core business activities. We manage economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources and duration of debt funding and the use of derivative financial instruments. Specifically, we enter into derivative financial instrument contracts to manage differences in the amount, timing and duration of known or expected cash receipts and known or expected cash payments principally related to existing borrowings.Cash Flow Hedges of Interest Rate RiskOur objectives in using interest rate derivatives are to add stability to interest expense and to manage exposure to interest rate movements. To accomplish these objectives, we primarily use interest rate cap agreements as part of our interest rate risk management strategy. Payments and receipts related to interest rate cap agreements are included in cash flows from financing activities in the consolidated statements of cash flows.During the three months ended December 31, 2021, two of our interest rate cap agreements expired. These agreements had a combined notional amount of $1,500,000. At December 31, 2021, each of our outstanding interest rate cap agreements were designated as cash flow hedges of interest rate risk and were determined to be highly effective. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on our variable-rate debt. We estimate that $2,038 will be reclassified as an increase to interest expense within one year.The fair value of derivative instruments is as follows: Fair Values of Derivative Financial Instruments Asset (Liability)Derivative financial instruments designated as hedging instruments: Balance Sheet Location December 31, 2021 March 31, 2021Interest rate cap agreements Other noncurrent assets, net $ 3,876 $ —Interest rate cap agreements Accrued expenses (1,331) (22,360)Interest rate cap agreements Other long-term liabilities — (365)Total $ 2,545 $ (22,725) Effect of Derivative Instruments on the Statement of OperationsThe effect of the derivative instruments on the consolidated statements of operations and other comprehensive income (loss) is as follows: Three Months Ended ‎ Nine Months Ended December 31, December 31, Derivative financial instruments in cash flow hedging relationships: 2021 2020 2021 2020Gain (loss) related to derivative financial instruments recognized in other comprehensive income (loss) $ 3,887 $ (383) $ 3,091 $ (7,119)(Gain) loss related to portion of derivative financial instruments reclassified from accumulated other comprehensive (income) loss to interest expense $ 708 $ 302 $ 1,664 $ 858 Credit Risk-Related Contingent FeaturesWe have agreements with each of our derivative counterparties providing that if we default on any of our indebtedness, including a default where repayment of the indebtedness has not been accelerated by the lender, then we also could be declared in default on our derivative obligations.As of December 31, 2021, the termination value of derivative financial instruments in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, was $2,552. If we had defaulted on any of our indebtedness at December 31, 2021, we could have been required to settle our obligations under the agreements at this termination value. We do not offset any derivative financial instruments and the derivative financial instruments are not subject to collateral posting requirements.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Dec. 31, 2021
Fair Value Measurements [Abstract]
Fair Value Measurements	9. Fair Value MeasurementsAssets and Liabilities Measured at Fair Value on a Recurring BasisThe following table summarizes our assets and liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fall: Quoted in Significant Other Significant Identical Markets Observable Inputs Unobservable Inputs Total (Level 1) (Level 2) (Level 3)Balance at December 31, 2021: Interest rate cap agreements $ 2,545 $ — $ 2,545 $ —Total $ 2,545 $ — $ 2,545 $ —Balance at March 31, 2021: Interest rate cap agreements $ (22,725) $ — $ (22,725) $ —Total $ (22,725) $ — $ (22,725) $ — Derivative Financial InstrumentsThe valuation of our derivative financial instruments is determined using widely accepted valuation techniques, including a discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivative, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair value of the interest rate cap agreements is determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the cap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. We incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we consider the impact of netting and any applicable credit enhancements. We measure the credit risk of our derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.Although we have determined that the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments utilize Level 3 inputs to evaluate the likelihood of both our own default and counterparty default. As of December 31, 2021, we determined that the credit valuation adjustments are not significant to the overall valuation of our derivatives and therefore, the valuations are classified in Level 2 of the fair value hierarchy.Contingent ConsiderationPrior to December 31, 2020, the valuation of our contingent consideration obligation was determined using a discounted cash flow method that involved a Monte Carlo simulation. This analysis reflects the contractual terms of the purchase agreements (i.e., minimum and maximum payments, length of earn-out periods, manner of calculating amounts due, etc.) and utilizes assumptions with regard to future cash flows that were determined using a Monte Carlo simulation which were then discounted to present value using an appropriate discount rate. Significant increases in future revenue assumptions would have resulted in a higher fair value measurement while an increase in the discount rate would have resulted in a lower fair value measurement. The measurement period ended December 31, 2020 at which point no obligations remained and the contingent consideration was reduced to zero.The table below presents a reconciliation of the fair value of the liabilities that use significant unobservable inputs (Level 3): Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Balance at beginning of period $ — $ — $ — $ (3,000)Gain (loss) included in Other, net — — — 3,000Balance at end of period $ — $ — $ — $ — Assets and Liabilities Measured at Fair Value upon Initial RecognitionThe carrying amount and the fair value of financial instruments held as of December 31, 2021 and March 31, 2021 were as follows: December 31, 2021 March 31, 2021 Carrying Amount Fair Value Carrying Amount Fair ValueCash and cash equivalents $ 96,011 $ 96,011 $ 113,101 $ 113,101Senior Credit Facilities (Level 2) $ 3,250,555 $ 3,313,250 $ 3,405,552 $ 3,488,883Senior Notes (Level 2) $ 1,319,284 $ 1,331,625 $ 1,318,079 $ 1,351,500Debt component of tangible equity units (Level 2) $ 8,390 $ 8,588 $ 20,345 $ 21,435 As described in Note 4, Business Combinations, the assets acquired and liabilities assumed as part of business acquisitions were recorded at fair value upon initial recognition.

Tangible Equity Units

Tangible Equity Units	9 Months Ended
	Dec. 31, 2021
Tangible Equity Units [Abstract]
Tangible Equity Units	10. Tangible Equity Units In July 2019, we completed our offering of 5,750,000 TEUs. Total proceeds, net of underwriting discounts, were $278,875. Each TEU, which has a stated amount of $50, is comprised of a stock purchase contract and a senior amortizing note due June 30, 2022. Unless settled earlier, each purchase contract will automatically settle on June 30, 2022. Holders of the purchase contracts may elect to early settle prior to June 30, 2022, at the minimum settlement rate of 3.2051 shares of common stock per purchase contract, resulting in the holder receiving the minimum number of shares for that purchase contract. In the event of certain types of changes in control (including the consummation of the UHG Transaction) or other specified Reorganization Events (as defined in the TEU agreements), each outstanding purchase contract will convert to a contract entitling the holder to receive cash or other assets that holders of the Company’s common stock are entitled to receive in the Reorganization Event. The amount of cash or other assets each holder is entitled to following a Reorganization Event is based on the Applicable Market Value and the corresponding settlement rate in effect at the time.The following table summarizes TEU activity: Tangible Equity UnitsOutstanding at March 31, 2020 5,137,345Issued —Conversions —Outstanding at December 31, 2020 5,137,345Outstanding at March 31, 2021 4,833,645Issued —Conversions (779,325)Outstanding at December 31, 2021 4,054,320

Tax Receivable Agreements

Tax Receivable Agreements	9 Months Ended
	Dec. 31, 2021
Tax Receivable Agreements [Abstract]
Tax Receivable Agreements	11. Tax Receivable Agreements As of December 31, 2021, we estimate the aggregate payments due under our tax receivable agreements in future fiscal years to be as follows:  Related Party ‎Tax Receivable Agreements McKesson ‎Tax Receivable Agreement Other ‎Tax Receivable Agreements TotalRemainder of 2022 $ — $ — $ — $ —2023 11,392 24,748 10,761 46,9012024 10,626 16,478 10,295 37,3992025 37,213 20,052 16,557 73,8222026 46,623 57,196 19,350 123,169Thereafter 63,323 39,785 49,777 152,885Gross expected payments 169,177 158,259 106,740 434,176Less: Amounts representing discount (57,220) — (31,280) (88,500)Total tax receivable agreement obligations 111,957 158,259 75,460 345,676Less: Current portion due (11,392) (24,748) (10,761) (46,901)Tax receivable agreement long-term obligations $ 100,565 $ 133,511 $ 64,699 $ 298,775The timing and/or amount of aggregate payments due may vary based on a number of factors, including the amount of net operating losses and income tax rates. The amount of aggregate payments shown above do not reflect any potential impacts from the UHG Transaction.

Income Taxes

Income Taxes	9 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Income Taxes	12. Income TaxesThe following table summarizes income tax information: Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Income tax provision (benefit) $ (10,115) $ (4,562) $ (35,313) $ (31,411)Effective tax rate 29.2% 192.8% 35.4% 24.1% Fluctuations in our reported income tax rates from the statutory rate are primarily due to the impacts of equity compensation, transaction costs, and benefits recognized for certain incentive tax credits resulting from research and experimental expenditures in the three and nine months ended December 31, 2021. For the three and nine months ended December 31, 2020, fluctuations in our reported income tax rates from the statutory rate are primarily due to our acquisition and divestiture activity, benefits recognized as a result of certain incentive tax credits resulting from research and experimental expenditures, and discrete items recognized.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Dec. 31, 2021
Net Income (Loss) Per Share [Abstract]
Net Income (Loss) Per Share	13. Net Income (Loss) Per ShareThe following table sets forth the computation of net income (loss) per share of common stock: Three Months Ended ‎December 31, Nine Months Ended ‎December 31,Basic net income (loss) per share: 2021 2020 2021 2020Numerator: Net income (loss) $ (24,472) $ 2,196 $ (64,480) $ (99,120)Denominator: Weighted average common shares outstanding 311,386,852 304,547,891 310,450,917 304,104,388Minimum shares issuable under purchase contracts 12,994,501 16,465,704 13,217,426 16,465,704Total weighted average shares outstanding 324,381,353 321,013,595 323,668,343 320,570,092Basic net income (loss) per share $ (0.08) $ 0.01 $ (0.20) $ (0.31)Diluted net income (loss) per share: Numerator: Net income (loss) $ (24,472) $ 2,196 $ (64,480) $ (99,120)Denominator: Number of shares used in basic computation 324,381,353 321,013,595 323,668,343 320,570,092Weighted average effect of dilutive securities Time-Vesting Options — 932,344 — —Restricted Share Units — 2,753,810 — —Deferred Stock Units — 95,624 — —Employee Stock Purchase Program Shares — 20,151 — —Total weighted average shares outstanding 324,381,353 324,815,524 323,668,343 320,570,092Diluted net income (loss) per share $ (0.08) $ 0.01 $ (0.20) $ (0.31) Due to their antidilutive effect, the following securities have been excluded from diluted net income (loss) per share: Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020Restricted Share Units 3,891,119 — 4,685,697 2,360,586Time-Vesting Options 1,538,279 — 1,681,928 766,432Deferred Stock Units 149,487 — 150,125 81,983Dilutive shares issuable under purchase contracts — — — 1,579,991

Legal Proceedings

Legal Proceedings	9 Months Ended
	Dec. 31, 2021
Legal Proceedings [Abstract]
Legal Proceedings	14. Legal ProceedingsWe are subject to various claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulators and other matters arising out of the normal conduct of its business. UHG Transaction ProceedingsFollowing the announcement of the UHG Transaction, nine lawsuits challenging the UHG Transaction were filed in various jurisdictions. The first lawsuit, a putative class action alleging breaches of fiduciary duty, was filed in Tennessee Chancery Court, and was voluntarily dismissed without prejudice on March 17, 2021. The remaining eight lawsuits were filed in federal court between March 18, 2021 and April 7, 2021. The operative complaints in those actions named us and our Board of Directors as defendants and alleged, among other things, that the proxy statement filed in conjunction with the UHG Transaction was materially incomplete and misleading in violation of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 and Rule 14a-9 promulgated thereunder (“Section 14(a) Actions”). All of the Section 14(a) Actions were dismissed without prejudice by April 23, 2021. We also received written demands from purported stockholders relating to the UHG Transaction. One of the stockholders who made a written demand subsequently filed a complaint against us in the Delaware Court of Chancery on April 13, 2021 pursuant to 8. Del. C. § 220, seeking certain books and records relating to the UHG Transaction. That action, which is captioned Waterford Township Policy & Fire Retirement System v. Change Healthcare, Inc., 2021-0317, remains pending and the parties have agreed to stay our deadline to respond to the operative pleading.Government Subpoenas and InvestigationsFrom time to time, we may receive subpoenas or requests for information from various government agencies. We generally respond to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in incurring considerable costs. Such subpoenas and requests also can lead to the assertion of claims or the commencement of civil or criminal proceedings against us and other members of the health care industry, as well as to settlements. Other MattersIn the ordinary course of business, we are involved in various other claims and legal proceedings. While the ultimate resolution of these matters has yet to be determined, we do not believe that it is reasonably possible that their outcomes will have a material adverse effect on our consolidated financial position, results of operations, or liquidity.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	15. Related Party Transactions Term Loans Held by Related PartyAffiliates of The Blackstone Group, L.P. (“Blackstone”) were significant stockholders at our inception and continue to hold a material interest in the Company. Certain investment funds managed by GSO Capital Partners LP (the “GSO-managed funds”) held a portion of the term loans under our Senior Credit Facilities. GSO Advisor Holdings LLC (“GSO Advisor”) is the general partner of GSO Capital Partners LP and Blackstone, indirectly through its subsidiaries, holds all of the issued and outstanding equity interests of GSO Advisor. As of December 31, 2021 and March 31, 2021, the GSO-managed funds held $252,131 and $162,189, respectively, in principal amount of the Senior Credit Facilities (none of which is classified within current portion of long-term debt).Transactions with Blackstone Portfolio Companies We provide various services to, and purchase services from, certain Blackstone portfolio companies under contracts that were executed in the normal course of business. The following is a summary of revenue recognized and amounts paid related to service provided to and from Blackstone portfolio companies: Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Revenue recognized related to services provided $ 1,467 $ 934 $ 4,915 $ 2,815Amount paid related to services received $ 3,785 $ 3,883 $ 12,726 $ 13,341 Employer Healthcare Program Agreement with Equity HealthcareEffective January 1, 2021, we entered into an employer health program agreement with Equity Healthcare LLC (“Equity Healthcare”), an affiliate of Blackstone, whereby Equity Healthcare provides certain negotiating, monitoring and other services in connection with certain of our health benefit plans. In consideration for Equity Healthcare’s services, we pay a fee of $3.00 per participating employee per month. Effective January 1, 2022, we will pay a fee of $3.25 per participating employee per month.eRx Network Option AgreementPrior to the creation of the Joint Venture, we entered into an option agreement to acquire eRx (the “Option Agreement”). Under the terms of the Option Agreement, the option to acquire eRx would only become exercisable at any such time that McKesson owns (directly or indirectly), in the aggregate, less than 5% of the outstanding units of the Joint Venture. Subsequent to the Merger, the Option became exercisable and was exercised on May 1, 2020. See Note 4, Business Combinations, for additional information.Transition Services AgreementsIn connection with the creation of the Joint Venture, we entered into transition services agreements with eRx. Under the agreements, we provided certain transition services to eRx in exchange for specified fees. Prior to the acquisition of eRx, we recognized $283 in transition fee income during the nine months ended December 31, 2020. The amounts received are included in Other, net in the consolidated statement of operations.

Segment Reporting

Segment Reporting	9 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment Reporting	16. Segment Reporting Management views the Company’s operating results based on three reportable segments: Software and Analytics, Network Solutions and Technology-Enabled Services. Software and AnalyticsThe Software and Analytics segment provides solutions for revenue cycle management, provider network management, payment accuracy, value-based payments, clinical decision support, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow.Network SolutionsThe Network Solutions segment provides solutions for financial, administrative, clinical and pharmacy transactions, electronic payments and aggregation and analytics of clinical and financial data.Technology-Enabled ServicesThe Technology-Enabled Services segment provides solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration and healthcare consulting.Postage and EliminationsPostage and eliminations includes pass-through postage costs, as well as eliminations to remove inter-segment revenue and expenses and consolidating adjustments to classify certain rebates paid to channel partners as a reduction of revenue. These administrative costs are excluded from the adjusted EBITDA measure for each respective reportable segment.Segment ResultsRevenue and adjusted EBITDA for each of the reportable segments for the three and nine months ended December 31, 2021 and 2020 are shown below. Information is reflected in the manner utilized by management to make operating decisions, assess performance and allocate resources. Such amounts include allocations of corporate shared services functions that are essential to the core operations of the reportable segments. Segment assets and related depreciation expenses are not presented to management for purposes of operational decision making, and therefore are not included in the accompanying tables. Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Segment Revenue Software and Analytics $ 386,020 $ 372,212 $ 1,169,760 $ 1,118,661Network Solutions 226,963 192,588 652,023 519,509Technology-Enabled Services 232,760 222,514 690,210 642,037Postage and Eliminations (1) 20,322 22,006 56,431 73,142Purchase Accounting Adjustment (2) — (24,179) (7,740) (118,088)Net Revenue $ 866,065 $ 785,141 $ 2,560,684 $ 2,235,261Segment Adjusted EBITDA Software and Analytics $ 125,131 $ 120,779 $ 397,814 $ 382,103Network Solutions 120,735 103,847 343,208 268,858Technology-Enabled Services 13,673 8,798 47,706 11,158Adjusted EBITDA $ 259,539 $ 233,424 $ 788,728 $ 662,119 Reconciliation of income (loss) before tax provision (benefit) to Adjusted EBITDA Income (loss) before income tax provision (benefit) $ (34,587) $ (2,366) $ (99,793) $ (130,531)Amortization of capitalized software developed for sale 935 460 2,510 550Depreciation and amortization 170,782 151,143 502,463 436,552Interest expense 58,433 61,439 177,284 185,733Equity compensation 24,807 10,944 74,718 34,858Acquisition accounting adjustments (4,864) 20,601 (7,077) 103,826Acquisition and divestiture-related costs 8,707 2,661 28,867 10,119Integration and related costs 5,894 9,688 23,195 27,581Strategic initiatives, duplicative and transition costs 13,492 4,324 38,064 13,169Severance costs 2,640 2,591 14,663 10,467Accretion and changes in estimate, net 4,482 (2,759) 13,570 8,429Impairment of long-lived assets and other 2,537 658 4,230 14,418Loss on extinguishment of debt 1,653 6,145 3,885 7,634Gain on sale of businesses — (32,217) — (60,487)Contingent consideration — — — (3,000)Other non-routine, net 4,628 112 12,149 2,801Adjusted EBITDA $ 259,539 $ 233,424 $ 788,728 $ 662,119 (1)Revenue for the Postage and Eliminations segment includes postage revenue of $54,917 and $49,877 for the three months ended December 31, 2021 and 2020, respectively, and $158,675 and $145,672 for the nine months ended December 31, 2021 and 2020, respectively.(2)Amount reflects the impact to deferred revenue resulting from the Merger which reduced revenue recognized during the period.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Abstract]
Accumulated Other Comprehensive Income (Loss)	17. Accumulated Other Comprehensive Income (Loss)The following is a summary of the accumulated other comprehensive income (loss) activity. Prior to the Merger, the activity in accumulated other comprehensive income (loss) reflects the Company’s proportionate share of the Joint Venture’s accumulated other comprehensive income (loss), net of taxes. Foreign Currency Accumulated Other Translation Cash Flow Comprehensive Adjustment Hedge Income (Loss)Balance at March 31, 2020 $ (7,084) $ (288) $ (7,372)Change associated with foreign currency translation 6,353 — 6,353Change associated with current period hedging — (4,459) (4,459)Reclassification into earnings — 275 275Balance at June 30, 2020 $ (731) $ (4,472) $ (5,203)Change associated with foreign currency translation 5,221 — 5,221Change associated with current period hedging — (2,277) (2,277)Reclassification into earnings — 281 281Balance at September 30, 2020 $ 4,490 $ (6,468) $ (1,978)Change associated with foreign currency translation 11,526 — 11,526Change associated with current period hedging — (383) (383)Reclassification into earnings — 302 302Balance at December 31, 2020 $ 16,016 $ (6,549) $ 9,467 Balance at March 31, 2021 $ 14,130 $ (2,909) $ 11,221Change associated with foreign currency translation 3,571 — 3,571Change associated with current period hedging — (294) (294)Reclassification into earnings — 413 413Balance at June 30, 2021 $ 17,701 $ (2,790) $ 14,911Change associated with foreign currency translation (2,156) — (2,156)Change associated with current period hedging — (502) (502)Reclassification into earnings — 543 543Balance at September 30, 2021 $ 15,545 $ (2,749) $ 12,796Change associated with foreign currency translation 3,693 — 3,693Change associated with current period hedging — 3,887 3,887Reclassification into earnings — 708 708Balance at December 31, 2021 $ 19,238 $ 1,846 $ 21,084

Significant Accounting Polici_2

Significant Accounting Policies (Policy)	9 Months Ended
	Dec. 31, 2021
Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”) Guidelines, Rules and Regulations and, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of results for the unaudited interim periods presented. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted. The results of operations for the interim period are not necessarily indicative of the results to be obtained for the full fiscal year. All intercompany accounts and transactions have been eliminated upon consolidation in the unaudited consolidated financial statements.
Revenue	RevenueWe recognize revenue at an amount that reflects the consideration we expect to be entitled to in exchange for transferring goods or services to a customer, in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). See Note 3, Revenue Recognition, for additional information.
Equity Compensation	Equity Compensation We measure stock-based compensation cost based on the estimated fair value of the award on the grant date and recognize the expense over the requisite service period, typically on a straight-line basis. We recognize stock-based compensation expense for awards with performance conditions if and when we conclude that it is probable that the performance conditions will be achieved. The fair value of equity awards is recognized as expense in the same period and in the same manner as if we had paid cash for the goods or services. Forfeitures are recognized as they occur. We issue new shares of common stock upon vesting of equity awards and upon exercise of vested options. We do not intend to repurchase any issued shares of common stock. During the three months ended December 31, 2021 and 2020 we recognized $24,807 and $10,944 of equity compensation expense, respectively. During the nine months ended December 31, 2021 and 2020 we recognized $74,718 and $34,858 of equity compensation expense, respectively. At December 31, 2021, aggregate unrecognized compensation expense related to outstanding awards was $197,183.Upon closing of the UHG Transaction, existing awards will generally convert to equivalent UHG awards with consistent vesting provisions. Certain awards will vest upon closing of the UHG Transaction per the terms of the UHG Agreement.
Allowance for Credit Losses	Allowance for Credit LossesThe allowance for credit losses of $23,370 and $24,126 at December 31, 2021 and March 31, 2021, respectively, was primarily based on historical credit loss experience, current conditions, future expected credit losses, and adjustments for certain asset-specific risk characteristics. The following table summarizes activity related to the allowance for credit losses: Nine Months Ended December 31, 2021 2020Balance at beginning of period $ 24,126 $ 22,360Cumulative effect of accounting change-ASU 2016-13 — 417Acquisitions and Dispositions (1) — (3,534)Provisions 6,084 11,623Write-offs (6,840) (6,863)Balance at end of period $ 23,370 $ 24,003 (1)For the nine months ended December 31, 2020, this amount relates primarily to the sale of Connected Analytics and Capacity Management.
Recently Adopted Accounting Pronouncements and Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements London Interbank Offered Rate (LIBOR) Reform In March 2020, the FASB issued ASU No. 2020-04, as amended by ASU No. 2021-01, which created Topic 848 – Reference Rate Reform. ASU No. 2020-04 contains optional practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts which may be elected over time as activities occur. Among other things, the ASU intends to ease the transition from LIBOR to an alternative reference rate. During the first quarter of fiscal year 2021, we elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. We continue to evaluate the impacts of ASU No. 2020-04 and may apply other elections as reference rate reform activities progress. Accounting Pronouncements Not Yet Adopted Derivatives and Convertible InstrumentsIn August 2020, the FASB issued ASU No. 2020-06 which simplifies the accounting for convertible instruments and amends the guidance addressing the derivatives scope exception for contracts in an entity’s own equity. The standard is scheduled to be effective for us beginning April 1, 2022. Given the forward purchase contracts of our Tangible Equity Units (“TEUs”) qualify for the derivatives scope exception and are currently accounted for under that guidance, we do not expect a material impact upon adoption. We will continue to evaluate the impact of this pronouncement prior to adoption.Contract Assets and Liabilities from Contracts with CustomersIn October 2021, the FASB issued ASU No. 2021-08 which improves the accounting for revenue contracts with customers acquired in a business combination by addressing diversity in practice and requiring the acquirer to measure contract assets and liabilities acquired in accordance with ASC 606. The standard is scheduled to be effective for us beginning April 1, 2023, with early adoption permitted. Once adopted, the updated guidance could potentially have a material impact on the amount of assets, liabilities, and revenue recognized from acquired businesses, depending on the size and nature of those transactions.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Dec. 31, 2021
Significant Accounting Policies [Abstract]
Summary of Activity Related to Allowance for Credit Losses	Nine Months Ended December 31, 2021 2020Balance at beginning of period $ 24,126 $ 22,360Cumulative effect of accounting change-ASU 2016-13 — 417Acquisitions and Dispositions (1) — (3,534)Provisions 6,084 11,623Write-offs (6,840) (6,863)Balance at end of period $ 23,370 $ 24,003 (1)For the nine months ended December 31, 2020, this amount relates primarily to the sale of Connected Analytics and Capacity Management.

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Dec. 31, 2021
eRx Network Holdings, Inc. [Member]
Business Acquisition [Line Items]
Summary of Information Related to Acquisition	eRxCash paid at closing$ 249,359Fair value of eRx purchase option 140,500Fair value of vested stock appreciation rights 5,097Cash paid for canceled eRx equity awards 5,891Total Consideration Fair Value at Acquisition Date$ 400,847 Allocation of the Consideration Transferred: Cash$ 54,108Accounts receivable 12,747Prepaid expenses and other current assets 609Goodwill 225,156Identifiable intangible assets: Customer relationships (life 17 years) 131,200Technology-based intangible assets (life 9-12 years) 29,700Other noncurrent assets 20Accounts payable (2,543)Accrued expenses and other current liabilities (10,933)Deferred income tax liabilities (39,217)Total consideration transferred$ 400,847
PDX, Inc. [Member]
Business Acquisition [Line Items]
Summary of Information Related to Acquisition	PDXCash$ 755Accounts receivable 5,739Prepaid expenses and other current assets 2,251Property and equipment 840Goodwill 98,830Identifiable intangible assets: Customer relationships (life 18 years) 74,300Technology-based intangible assets (life 10-11 years) 25,300Other noncurrent assets 690Accounts payable (3,882)Deferred revenue, current (2,946)Accrued expenses and other current liabilities (3,364)Other long-term liabilities (222)Total consideration transferred$ 198,291

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Dec. 31, 2021
Goodwill [Abstract]
Schedule of Goodwill	ssss Software and Analytics Network Solutions Technology-Enabled Services TotalBalance at March 31, 2021 $ 1,758,302 $ 1,970,739 $ 379,752 $ 4,108,792Acquisitions — — — —Dispositions — — — —Effects of foreign currency 6,032 — — 6,032Adjustments (142) — — (142)Balance at December 31, 2021 $ 1,764,192 $ 1,970,739 $ 379,752 $ 4,114,682

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Dec. 31, 2021
Long-Term Debt [Abstract]
Schedule of Long-Term Debt	December 31, 2021 March 31, 2021Senior Credit Facilities $5,100,000 Term Loan Facility, due March 1, 2024, net of unamortized discount of $62,695 and $87,698 at December 31, 2021 and March 31, 2021, respectively (effective interest rate of 4.42% and 4.42%, respectively) $ 3,250,555 $ 3,405,552$785,000 Revolving Facility, expiring July 3, 2024, and bearing interest at a variable interest rate — —Senior Notes $1,325,000 5.75% Senior Notes due March 1, 2025, net of unamortized discount of $5,716 and $6,921 at December 31, 2021 and March 31, 2021, respectively (effective interest rate of 5.90% and 5.90%, respectively) 1,319,284 1,318,079Tangible Equity Unit Senior Amortizing Note $47,367 Senior Amortizing Notes due June 30, 2022, net of unamortized discount of $60 and $293 at December 31, 2021 and March 31, 2021, respectively (effective interest rate of 7.44% and 7.44%, respectively) 8,390 20,345Other 9,645 18,138Less current portion (15,009) (27,339)Long-term debt, excluding current portion $ 4,572,865 $ 4,734,775

Interest Rate Cap Agreements (T

Interest Rate Cap Agreements (Tables)	9 Months Ended
	Dec. 31, 2021
Interest Rate Cap Agreements [Abstract]
Schedule of Fair Value of Derivative Instruments	Fair Values of Derivative Financial Instruments Asset (Liability)Derivative financial instruments designated as hedging instruments: Balance Sheet Location December 31, 2021 March 31, 2021Interest rate cap agreements Other noncurrent assets, net $ 3,876 $ —Interest rate cap agreements Accrued expenses (1,331) (22,360)Interest rate cap agreements Other long-term liabilities — (365)Total $ 2,545 $ (22,725)
Schedule of Effect of Derivative Instruments on Statement of Operations	Three Months Ended ‎ Nine Months Ended December 31, December 31, Derivative financial instruments in cash flow hedging relationships: 2021 2020 2021 2020Gain (loss) related to derivative financial instruments recognized in other comprehensive income (loss) $ 3,887 $ (383) $ 3,091 $ (7,119)(Gain) loss related to portion of derivative financial instruments reclassified from accumulated other comprehensive (income) loss to interest expense $ 708 $ 302 $ 1,664 $ 858

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Dec. 31, 2021
Fair Value Measurements [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	Quoted in Significant Other Significant Identical Markets Observable Inputs Unobservable Inputs Total (Level 1) (Level 2) (Level 3)Balance at December 31, 2021: Interest rate cap agreements $ 2,545 $ — $ 2,545 $ —Total $ 2,545 $ — $ 2,545 $ —Balance at March 31, 2021: Interest rate cap agreements $ (22,725) $ — $ (22,725) $ —Total $ (22,725) $ — $ (22,725) $ —
Reconciliation of Fair Value Derivative Using Unobservable Inputs	Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Balance at beginning of period $ — $ — $ — $ (3,000)Gain (loss) included in Other, net — — — 3,000Balance at end of period $ — $ — $ — $ —
Carrying Amount and Estimated Fair Value of Financial Instruments	December 31, 2021 March 31, 2021 Carrying Amount Fair Value Carrying Amount Fair ValueCash and cash equivalents $ 96,011 $ 96,011 $ 113,101 $ 113,101Senior Credit Facilities (Level 2) $ 3,250,555 $ 3,313,250 $ 3,405,552 $ 3,488,883Senior Notes (Level 2) $ 1,319,284 $ 1,331,625 $ 1,318,079 $ 1,351,500Debt component of tangible equity units (Level 2) $ 8,390 $ 8,588 $ 20,345 $ 21,435

Tangible Equity Units (Tables)

Tangible Equity Units (Tables)	9 Months Ended
	Dec. 31, 2021
Tangible Equity Units [Abstract]
Schedule of Tangible Equity Units Activity	Tangible Equity UnitsOutstanding at March 31, 2020 5,137,345Issued —Conversions —Outstanding at December 31, 2020 5,137,345Outstanding at March 31, 2021 4,833,645Issued —Conversions (779,325)Outstanding at December 31, 2021 4,054,320

Tax Receivable Agreements (Tabl

Tax Receivable Agreements (Tables)	9 Months Ended
	Dec. 31, 2021
Tax Receivable Agreements [Abstract]
Aggregate Payments Due Under Tax Receivable Agreements	Related Party ‎Tax Receivable Agreements McKesson ‎Tax Receivable Agreement Other ‎Tax Receivable Agreements TotalRemainder of 2022 $ — $ — $ — $ —2023 11,392 24,748 10,761 46,9012024 10,626 16,478 10,295 37,3992025 37,213 20,052 16,557 73,8222026 46,623 57,196 19,350 123,169Thereafter 63,323 39,785 49,777 152,885Gross expected payments 169,177 158,259 106,740 434,176Less: Amounts representing discount (57,220) — (31,280) (88,500)Total tax receivable agreement obligations 111,957 158,259 75,460 345,676Less: Current portion due (11,392) (24,748) (10,761) (46,901)Tax receivable agreement long-term obligations $ 100,565 $ 133,511 $ 64,699 $ 298,775

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Summary of Income Tax Information	Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Income tax provision (benefit) $ (10,115) $ (4,562) $ (35,313) $ (31,411)Effective tax rate 29.2% 192.8% 35.4% 24.1%

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Dec. 31, 2021
Net Income (Loss) Per Share [Abstract]
Computation of Basic Net Income (Loss) Per Share of Common Stock	Three Months Ended ‎December 31, Nine Months Ended ‎December 31,Basic net income (loss) per share: 2021 2020 2021 2020Numerator: Net income (loss) $ (24,472) $ 2,196 $ (64,480) $ (99,120)Denominator: Weighted average common shares outstanding 311,386,852 304,547,891 310,450,917 304,104,388Minimum shares issuable under purchase contracts 12,994,501 16,465,704 13,217,426 16,465,704Total weighted average shares outstanding 324,381,353 321,013,595 323,668,343 320,570,092Basic net income (loss) per share $ (0.08) $ 0.01 $ (0.20) $ (0.31)Diluted net income (loss) per share: Numerator: Net income (loss) $ (24,472) $ 2,196 $ (64,480) $ (99,120)Denominator: Number of shares used in basic computation 324,381,353 321,013,595 323,668,343 320,570,092Weighted average effect of dilutive securities Time-Vesting Options — 932,344 — —Restricted Share Units — 2,753,810 — —Deferred Stock Units — 95,624 — —Employee Stock Purchase Program Shares — 20,151 — —Total weighted average shares outstanding 324,381,353 324,815,524 323,668,343 320,570,092Diluted net income (loss) per share $ (0.08) $ 0.01 $ (0.20) $ (0.31)
Antidilutive Securities Excluded from Diluted Net Income (Loss) Per Share	Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020Restricted Share Units 3,891,119 — 4,685,697 2,360,586Time-Vesting Options 1,538,279 — 1,681,928 766,432Deferred Stock Units 149,487 — 150,125 81,983Dilutive shares issuable under purchase contracts — — — 1,579,991

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Summary of Revenue Recognized and Amounts Paid Related to Service Provided to and from Portfolio Companies	Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Revenue recognized related to services provided $ 1,467 $ 934 $ 4,915 $ 2,815Amount paid related to services received $ 3,785 $ 3,883 $ 12,726 $ 13,341

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Revenue and Adjusted EBITDA for each Reportable Segment	Three Months Ended Nine Months Ended December 31, December 31, 2021 2020 2021 2020Segment Revenue Software and Analytics $ 386,020 $ 372,212 $ 1,169,760 $ 1,118,661Network Solutions 226,963 192,588 652,023 519,509Technology-Enabled Services 232,760 222,514 690,210 642,037Postage and Eliminations (1) 20,322 22,006 56,431 73,142Purchase Accounting Adjustment (2) — (24,179) (7,740) (118,088)Net Revenue $ 866,065 $ 785,141 $ 2,560,684 $ 2,235,261Segment Adjusted EBITDA Software and Analytics $ 125,131 $ 120,779 $ 397,814 $ 382,103Network Solutions 120,735 103,847 343,208 268,858Technology-Enabled Services 13,673 8,798 47,706 11,158Adjusted EBITDA $ 259,539 $ 233,424 $ 788,728 $ 662,119 Reconciliation of income (loss) before tax provision (benefit) to Adjusted EBITDA Income (loss) before income tax provision (benefit) $ (34,587) $ (2,366) $ (99,793) $ (130,531)Amortization of capitalized software developed for sale 935 460 2,510 550Depreciation and amortization 170,782 151,143 502,463 436,552Interest expense 58,433 61,439 177,284 185,733Equity compensation 24,807 10,944 74,718 34,858Acquisition accounting adjustments (4,864) 20,601 (7,077) 103,826Acquisition and divestiture-related costs 8,707 2,661 28,867 10,119Integration and related costs 5,894 9,688 23,195 27,581Strategic initiatives, duplicative and transition costs 13,492 4,324 38,064 13,169Severance costs 2,640 2,591 14,663 10,467Accretion and changes in estimate, net 4,482 (2,759) 13,570 8,429Impairment of long-lived assets and other 2,537 658 4,230 14,418Loss on extinguishment of debt 1,653 6,145 3,885 7,634Gain on sale of businesses — (32,217) — (60,487)Contingent consideration — — — (3,000)Other non-routine, net 4,628 112 12,149 2,801Adjusted EBITDA $ 259,539 $ 233,424 $ 788,728 $ 662,119 (1)Revenue for the Postage and Eliminations segment includes postage revenue of $54,917 and $49,877 for the three months ended December 31, 2021 and 2020, respectively, and $158,675 and $145,672 for the nine months ended December 31, 2021 and 2020, respectively.(2)Amount reflects the impact to deferred revenue resulting from the Merger which reduced revenue recognized during the period.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Abstract]
Summary of Accumulated Other Comprehensive Income (Loss)	Foreign Currency Accumulated Other Translation Cash Flow Comprehensive Adjustment Hedge Income (Loss)Balance at March 31, 2020 $ (7,084) $ (288) $ (7,372)Change associated with foreign currency translation 6,353 — 6,353Change associated with current period hedging — (4,459) (4,459)Reclassification into earnings — 275 275Balance at June 30, 2020 $ (731) $ (4,472) $ (5,203)Change associated with foreign currency translation 5,221 — 5,221Change associated with current period hedging — (2,277) (2,277)Reclassification into earnings — 281 281Balance at September 30, 2020 $ 4,490 $ (6,468) $ (1,978)Change associated with foreign currency translation 11,526 — 11,526Change associated with current period hedging — (383) (383)Reclassification into earnings — 302 302Balance at December 31, 2020 $ 16,016 $ (6,549) $ 9,467 Balance at March 31, 2021 $ 14,130 $ (2,909) $ 11,221Change associated with foreign currency translation 3,571 — 3,571Change associated with current period hedging — (294) (294)Reclassification into earnings — 413 413Balance at June 30, 2021 $ 17,701 $ (2,790) $ 14,911Change associated with foreign currency translation (2,156) — (2,156)Change associated with current period hedging — (502) (502)Reclassification into earnings — 543 543Balance at September 30, 2021 $ 15,545 $ (2,749) $ 12,796Change associated with foreign currency translation 3,693 — 3,693Change associated with current period hedging — 3,887 3,887Reclassification into earnings — 708 708Balance at December 31, 2021 $ 19,238 $ 1,846 $ 21,084

Nature of Business and Organi_2

Nature of Business and Organization (Narrative) (Details) - $ / shares	Jul. 01, 2019	Dec. 31, 2021	Jan. 05, 2021
Change Healthcare LLC [Member]
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Ownership percentage		100.00%
Joint Venture [Member]
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Ownership percentage	41.00%
Change Healthcare Inc. [Member]
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Business acquisition, share price			$ 25.75

Significant Accounting Polici_4

Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Significant Accounting Policies [Line Items]
Equity compensation expense	$ 24,807	$ 10,944	$ 74,718	$ 34,858
Unrecognized compensation expense	197,183		197,183
Allowance for credit losses	$ 23,370	$ 24,003	$ 23,370	$ 24,003	$ 24,126	$ 22,360

Significant Accounting Polici_5

Significant Accounting Policies (Summary of Activity Related to Allowance for Credit Losses) (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accounts Receivable, Allowance for Credit Loss [Line Items]
Balance at beginning of period	$ 24,126	$ 22,360
Acquisitions and Dispositions		(3,534)
Provisions	6,084	11,623
Write-offs	(6,840)	(6,863)
Balance at end of period	$ 23,370	24,003
Accumulated Deficit [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] | ASU 2016-13 [Member]
Accounts Receivable, Allowance for Credit Loss [Line Items]
Balance at beginning of period		$ 417

Revenue Recognition (Narrative)

Revenue Recognition (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Line Items]
Percentage of deferred revenue balance expected to be recognized in one year or less			95.00%
Deferred revenue recognized			$ 365,086	$ 245,760
Remaining performance obligation	$ 1,349,496		$ 1,349,496
Over Time [Member]
Revenue from Contract with Customer [Line Items]
Percentage of deferred revenue balance expected to be recognized in one year or less		98.00%		96.00%
Percentage of revenue recognized	97.00%		96.00%
Point in Time [Member]
Revenue from Contract with Customer [Line Items]
Percentage of deferred revenue balance expected to be recognized in one year or less		2.00%		4.00%
Percentage of revenue recognized	3.00%		4.00%

Revenue Recognition (Remaining

Revenue Recognition (Remaining Performance Obligation - Narrative) (Details)	Dec. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, expected satisfaction, period	12 months
Remaining performance obligation, percentage	51.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, expected satisfaction, period	1 year
Remaining performance obligation, percentage	49.00%

Business Combinations (eRx Netw

Business Combinations (eRx Network Holdings, Inc. - Narrative) (Details) - eRx Network Holdings, Inc. [Member] - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2020	May 01, 2020
Business Acquisition [Line Items]
Ownership interest acquired		100.00%
Remeasurement loss	$ 6,000

Business Combinations (PDX, Inc

Business Combinations (PDX, Inc. - Narrative) (Details) - PDX, Inc. [Member] $ in Thousands	Jun. 01, 2020USD ($)
Business Acquisition [Line Items]
Ownership interest acquired	100.00%
Total consideration	$ 198,291

Business Combinations (eRx Ne_2

Business Combinations (eRx Network Holdings, Inc. - Summary of Information Related to Acquisition) (Details) - USD ($) $ in Thousands	May 01, 2020	Dec. 31, 2021	Mar. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 4,114,682	$ 4,108,792
eRx Network Holdings, Inc. [Member]
Business Acquisition [Line Items]
Cash paid at closing	$ 249,359
Fair value of eRx purchase option	140,500
Fair value of vested stock appreciation rights	5,097
Cash paid for canceled eRx equity awards	5,891
Total Consideration Fair Value at Acquisition Date	400,847
Cash	54,108
Accounts receivable	12,747
Prepaid expenses and other current assets	609
Goodwill	225,156
Other noncurrent assets	20
Accounts payable	(2,543)
Accrued expenses and other current liabilities	(10,933)
Deferred income tax liabilities	(39,217)
Total consideration transferred	400,847
Customer Relationships [Member] | eRx Network Holdings, Inc. [Member]
Business Acquisition [Line Items]
Identified intangible assets	$ 131,200
Useful life	17 years
Technology-Based Intangible Assets [Member] | eRx Network Holdings, Inc. [Member]
Business Acquisition [Line Items]
Identified intangible assets	$ 29,700
Technology-Based Intangible Assets [Member] | eRx Network Holdings, Inc. [Member] | Minimum [Member]
Business Acquisition [Line Items]
Useful life	9 years
Technology-Based Intangible Assets [Member] | eRx Network Holdings, Inc. [Member] | Maximum [Member]
Business Acquisition [Line Items]
Useful life	12 years

Business Combinations (PDX, I_2

Business Combinations (PDX, Inc. - Summary of Information Related to Acquisition) (Details) - USD ($) $ in Thousands	Jun. 01, 2020	Dec. 31, 2021	Mar. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 4,114,682	$ 4,108,792
PDX, Inc. [Member]
Business Acquisition [Line Items]
Cash	$ 755
Accounts receivable	5,739
Prepaid expenses and other current assets	2,251
Property and equipment	840
Goodwill	98,830
Other noncurrent assets	690
Accounts payable	(3,882)
Deferred revenue, current	(2,946)
Accrued expenses and other current liabilities	(3,364)
Other long-term liabilities	(222)
Total consideration transferred	198,291
Customer Relationships [Member] | PDX, Inc. [Member]
Business Acquisition [Line Items]
Identified intangible assets	$ 74,300
Useful life	18 years
Technology-Based Intangible Assets [Member] | PDX, Inc. [Member]
Business Acquisition [Line Items]
Identified intangible assets	$ 25,300
Technology-Based Intangible Assets [Member] | PDX, Inc. [Member] | Minimum [Member]
Business Acquisition [Line Items]
Useful life	10 years
Technology-Based Intangible Assets [Member] | PDX, Inc. [Member] | Maximum [Member]
Business Acquisition [Line Items]
Useful life	11 years

Dispositions (Narrative) (Detai

Dispositions (Narrative) (Details) - USD ($) $ in Thousands

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Jul. 31, 2020

Dec. 31, 2020

Dec. 31, 2020

Mar. 31, 2021

Dec. 31, 2021

Sep. 30, 2021

Jun. 30, 2021

Dec. 02, 2020

Dec. 01, 2020

Sep. 30, 2020

Jun. 30, 2020

May 01, 2020

Apr. 30, 2020

Mar. 31, 2020

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Net book value

$ 3,233,738

$ 3,233,738

$ 3,252,228

$ 3,247,595

$ 3,244,166

$ 3,263,853

$ 3,209,250

$ 3,239,354

$ 3,285,447

Gain on sale of business

$ 32,217

$ 60,487

Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] | Connected Analytics [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Consideration

$ 55,000

Net book value

$ 23,428

Net accounts receivable

16,636

Goodwill

21,705

Deferred revenue

$ 17,083

Gain on sale of business

24,337

Payment received on notes receivable

$ 25,000

Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] | Connected Analytics [Member] | Notes Receivable [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Other noncurrent assets

$ 25,000

Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] | Capacity Management [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Consideration

$ 67,500

Net book value

$ 31,690

Net accounts receivable

14,991

Goodwill

26,944

Deferred revenue

$ 15,230

Gain on sale of business

$ 31,690

Goodwill (Schedule of Goodwill)

Goodwill (Schedule of Goodwill) (Details) $ in Thousands	9 Months Ended
	Dec. 31, 2021USD ($)
Goodwill [Line Items]
Balance at March 31, 2021	$ 4,108,792
Effects of foreign currency	6,032
Adjustments	(142)
Balance at December 31, 2021	4,114,682
Software and Analytics [Member]
Goodwill [Line Items]
Balance at March 31, 2021	1,758,302
Effects of foreign currency	6,032
Adjustments	(142)
Balance at December 31, 2021	1,764,192
Network Solutions [Member]
Goodwill [Line Items]
Balance at March 31, 2021	1,970,739
Balance at December 31, 2021	1,970,739
Technology-Enabled Services [Member]
Goodwill [Line Items]
Balance at March 31, 2021	379,752
Balance at December 31, 2021	$ 379,752

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2021
Debt Instrument [Line Items]
Payments on Term Loan Facility			$ 180,000	$ 265,000
Loss on extinguishment of debt	$ 1,653	$ 6,145	$ 3,885	$ 7,634
Term Loan Facility [Member]
Debt Instrument [Line Items]
Maturity date			Mar. 1, 2024
Payments on Term Loan Facility	80,000
Loss on extinguishment of debt	$ 1,653
Senior Notes due March 1, 2025 [Member]
Debt Instrument [Line Items]
Stated interest rate	5.75%		5.75%		5.75%
Maturity date			Mar. 1, 2025

Long-Term Debt (Schedule of Lon

Long-Term Debt (Schedule of Long-Term Debt) (Details) - USD ($)	9 Months Ended
	Dec. 31, 2021	Mar. 31, 2021
Debt Instrument [Line Items]
Less current portion	$ (15,009,000)	$ (27,339,000)
Long-term debt, excluding current portion	4,572,865,000	4,734,775,000
Senior Notes due March 1, 2025 [Member]
Debt Instrument [Line Items]
Long-term debt	1,319,284,000	1,318,079,000
Debt instrument, face amount	$ 1,325,000,000	$ 1,325,000,000
Stated interest rate	5.75%	5.75%
Maturity date	Mar. 1, 2025
Unamortized discount	$ 5,716,000	$ 6,921,000
Effective interest rate	5.90%	5.90%
Senior Amortizing Notes due June 30, 2022 [Member]
Debt Instrument [Line Items]
Long-term debt	$ 8,390,000	$ 20,345,000
Debt instrument, face amount	$ 47,367,000	47,367,000
Maturity date	Jun. 30, 2022
Unamortized discount	$ 60,000	$ 293,000
Effective interest rate	7.44%	7.44%
Other [Member]
Debt Instrument [Line Items]
Long-term debt	$ 9,645,000	$ 18,138,000
Term Loan Facility [Member]
Debt Instrument [Line Items]
Long-term debt	3,250,555,000	3,405,552,000
Debt instrument, face amount	$ 5,100,000,000	5,100,000,000
Maturity date	Mar. 1, 2024
Unamortized discount	$ 62,695,000	$ 87,698,000
Effective interest rate	4.42%	4.42%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt
Debt instrument, face amount	$ 785,000,000	$ 785,000,000
Maturity date	Jul. 3, 2024

Interest Rate Cap Agreements (N

Interest Rate Cap Agreements (Narrative) (Details) $ in Thousands	9 Months Ended
	Dec. 31, 2021USD ($)item
Derivative [Line Items]
Reclassified as interest expense	$ 2,038
Fair value derivative net liability	$ 2,552
Interest Rate Cap Agreements [Member]
Derivative [Line Items]
Number of agreements expired | item	2
Notional amount	$ 1,500

Interest Rate Cap Agreements (S

Interest Rate Cap Agreements (Schedule of Fair Value of Derivative Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Mar. 31, 2021
Derivatives Fair Value [Line Items]
Other noncurrent assets, net	$ 542,100	$ 430,141
Accrued expenses	(473,470)	(484,293)
Other long-term liabilities	(64,861)	(65,572)
Fair Values of Derivative Instruments Asset (Liability) Derivatives	(2,552)
Designated as Hedging Instrument [Member] | Interest Rate Cap Agreements [Member]
Derivatives Fair Value [Line Items]
Other noncurrent assets, net	3,876
Accrued expenses	(1,331)	(22,360)
Other long-term liabilities		(365)
Fair Values of Derivative Instruments Asset (Liability) Derivatives	$ 2,545	$ (22,725)

Interest Rate Cap Agreements _2

Interest Rate Cap Agreements (Schedule of Effect of Derivative Instruments on Statement of Operations) (Details) - Cash Flow Hedging [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) related to derivative financial instruments recognized in other comprehensive income (loss)	$ 3,887	$ (383)	$ 3,091	$ (7,119)
Gain (loss) related to portion of derivative financial instruments reclassified from accumulated other comprehensive income (loss) to interest expense	$ 708	$ 302	$ 1,664	$ 858

Fair Value Measurements (Narrat

Fair Value Measurements (Narrative) (Details)	Dec. 31, 2020USD ($)
Fair Value Measurements [Abstract]
Contingent consideration liability	$ 0

Fair Value Measurements (Schedu

Fair Value Measurements (Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Mar. 31, 2021
Derivatives Fair Value [Line Items]
Interest rate cap agreements	$ 2,545
Interest rate cap agreements		$ (22,725)
Total	2,545	(22,725)
Significant Other Observable Inputs (Level 2)
Derivatives Fair Value [Line Items]
Interest rate cap agreements	2,545
Interest rate cap agreements		(22,725)
Total	$ 2,545	$ (22,725)

Fair Value Measurements (Reconc

Fair Value Measurements (Reconciliation of Fair Value Derivative Using Unobservable Inputs) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Fair Value Measurements [Abstract]
Balance at beginning of period				$ (3,000)
Gain (loss) included in Other, net				3,000
Balance at end of period

Fair Value Measurements (Carryi

Fair Value Measurements (Carrying Amount and Estimated Fair Value of Financial Instruments) (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Dec. 31, 2021	Mar. 31, 2021
Carrying [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 96,011	$ 113,101
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	96,011	113,101
Senior Notes due March 1, 2025 [Member] | Significant Other Observable Inputs (Level 2) | Carrying [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	1,319,284	1,318,079
Senior Notes due March 1, 2025 [Member] | Significant Other Observable Inputs (Level 2) | Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	1,331,625	1,351,500
Senior Amortizing Notes due June 30, 2022 [Member] | Significant Other Observable Inputs (Level 2) | Carrying [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt component of tangible equity units	8,390	20,345
Senior Amortizing Notes due June 30, 2022 [Member] | Significant Other Observable Inputs (Level 2) | Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt component of tangible equity units	8,588	21,435
Senior Credit Facilities [Member] | Significant Other Observable Inputs (Level 2) | Carrying [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	3,250,555	3,405,552
Senior Credit Facilities [Member] | Significant Other Observable Inputs (Level 2) | Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	$ 3,313,250	$ 3,488,883

Tangible Equity Units (Narrativ

Tangible Equity Units (Narrative) (Details) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended
	Jul. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2021shares	Dec. 31, 2020shares
Tangible Equity Units [Line Items]
Conversion to shares		3.2051
Senior Amortizing Note [Member]
Tangible Equity Units [Line Items]
Maturity date		Jun. 30, 2022
Settlement date		Jun. 30, 2022
Tangible Equity Units [Member]
Tangible Equity Units [Line Items]
Tangible equity unit offering | shares	5,750,000
Total proceeds, net of issuance costs | $	$ 278,875
TEU price per share | $ / shares	$ 50

Tangible Equity Units (Schedule

Tangible Equity Units (Schedule of Tangible Equity Units Activity) (Details) - Tangible Equity Units [Member] - shares	1 Months Ended	9 Months Ended
	Jul. 31, 2019	Dec. 31, 2021	Dec. 31, 2020
Tangible Equity Units [Line Items]
Outstanding at March 31,		4,833,645	5,137,345
Issued	5,750,000
Conversions		(779,325)
Outstanding at December 31,		4,054,320	5,137,345

Tax Receivable Agreements (Aggr

Tax Receivable Agreements (Aggregate Payments Due Under Tax Receivable Agreements (Details) $ in Thousands	Dec. 31, 2021USD ($)
Related Party Transaction [Line Items]
2023	$ 46,901
2024	37,399
2025	73,822
2026	123,169
Thereafter	152,885
Gross expected payments	434,176
Less: Amounts representing discount	(88,500)
Total tax receivable agreement obligations	345,676
Less: Current portion due	(46,901)
Tax receivable agreement long-term obligations	298,775
Related Party Tax Receivable Agreements [Member]
Related Party Transaction [Line Items]
2023	11,392
2024	10,626
2025	37,213
2026	46,623
Thereafter	63,323
Gross expected payments	169,177
Less: Amounts representing discount	(57,220)
Total tax receivable agreement obligations	111,957
Less: Current portion due	(11,392)
Tax receivable agreement long-term obligations	100,565
McKesson Tax Receivable Agreement [Member]
Related Party Transaction [Line Items]
2023	24,748
2024	16,478
2025	20,052
2026	57,196
Thereafter	39,785
Gross expected payments	158,259
Total tax receivable agreement obligations	158,259
Less: Current portion due	(24,748)
Tax receivable agreement long-term obligations	133,511
Other Tax Receivable Agreements [Member]
Related Party Transaction [Line Items]
2023	10,761
2024	10,295
2025	16,557
2026	19,350
Thereafter	49,777
Gross expected payments	106,740
Less: Amounts representing discount	(31,280)
Total tax receivable agreement obligations	75,460
Less: Current portion due	(10,761)
Tax receivable agreement long-term obligations	$ 64,699

Income Taxes (Summary of Income

Income Taxes (Summary of Income Tax Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Income tax provision (benefit)	$ (10,115)	$ (4,562)	$ (35,313)	$ (31,411)
Effective tax rate	29.20%	192.80%	35.40%	24.10%

Net Income (Loss) Per Share (Co

Net Income (Loss) Per Share (Computation of Basic Net Income (Loss) Per Share of Common Stock) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Line Items]
Net income (loss)	$ (24,472)	$ (36,404)	$ (3,605)	$ 2,196	$ (42,622)	$ (58,694)	$ (64,480)	$ (99,120)
Weighted average common shares outstanding	311,386,852			304,547,891			310,450,917	304,104,388
Minimum shares issuable under purchase contracts	12,994,501			16,465,704			13,217,426	16,465,704
Total weighted average shares outstanding	324,381,353			321,013,595			323,668,343	320,570,092
Basic net income (loss) per share	$ (0.08)			$ 0.01			$ (0.20)	$ (0.31)
Diluted net income per share:
Net income (loss)	$ (24,472)	$ (36,404)	$ (3,605)	$ 2,196	$ (42,622)	$ (58,694)	$ (64,480)	$ (99,120)
Number of shares used in basic computation	324,381,353			321,013,595			323,668,343	320,570,092
Total weighted average shares outstanding	324,381,353			324,815,524			323,668,343	320,570,092
Diluted net income (loss) per share	$ (0.08)			$ 0.01			$ (0.20)	$ (0.31)
Time-Vesting Options [Member]
Diluted net income per share:
Weighted average effect of dilutive securities				932,344
Restricted Stock Units [Member]
Diluted net income per share:
Weighted average effect of dilutive securities				2,753,810
Deferred Stock Units [Member]
Diluted net income per share:
Weighted average effect of dilutive securities				95,624
Employee Stock Purchase Program Shares [Member]
Diluted net income per share:
Weighted average effect of dilutive securities				20,151

Net Income (Loss) Per Share (An

Net Income (Loss) Per Share (Antidilutive Securities Excluded from Diluted Net Income (Loss) Per Share) (Details) - shares	3 Months Ended	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Dilutive Shares Issuable Under Purchase Contracts [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from diluted net income (loss) per share			1,579,991
Time-Vesting Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from diluted net income (loss) per share	1,538,279	1,681,928	766,432
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from diluted net income (loss) per share	3,891,119	4,685,697	2,360,586
Deferred Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from diluted net income (loss) per share	149,487	150,125	81,983

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details) $ in Thousands	Jan. 01, 2022$ / employee	Dec. 31, 2021USD ($)$ / employee	Dec. 31, 2020USD ($)	Mar. 31, 2021USD ($)
Related Party Transaction [Line Items]
Long-term debt, excluding current portion		$ 4,572,865		$ 4,734,775
Employer Healthcare Program Agreement [Member]
Related Party Transaction [Line Items]
Service fee per participating employee per month | $ / employee		3
Option Agreement [Member[ | McKesson Corporation [Member]
Related Party Transaction [Line Items]
Maximum percentage of ownership in the outstanding units of the Joint Venture allowed for option to acquire can be exercised		5.00%
Transition Services Agreements [Member]
Related Party Transaction [Line Items]
Transition fee income			$ 283
Senior Credit Facilities [Member] | GSO-Managed Funds [Member]
Related Party Transaction [Line Items]
Long-term debt, excluding current portion		$ 252,131		$ 162,189
Subsequent Event [Member] | Employer Healthcare Program Agreement [Member]
Related Party Transaction [Line Items]
Service fee per participating employee per month | $ / employee	3.25

Related Party Transactions (Sum

Related Party Transactions (Summary of Revenue Recognized and Amounts Paid Related to Service Provided to and from Portfolio Companies) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Revenue recognized related to services provided	$ 1,467	$ 934	$ 4,915	$ 2,815
Amount paid related to services received	$ 3,785	$ 3,883	$ 12,726	$ 13,341

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details)	9 Months Ended
	Dec. 31, 2021segment
Segment Reporting [Abstract]
Number of reportable segments	3

Segment Reporting (Revenue and

Segment Reporting (Revenue and Adjusted EBITDA for each Reportable Segment) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Net revenue	$ 866,065	$ 785,141	$ 2,560,684	$ 2,235,261
Adjusted EBITDA	259,539	233,424	788,728	662,119
Reconciliation of income (loss) before tax provision (benefit) to Adjusted EBITDA
Income (loss) before income tax provision (benefit)	(34,587)	(2,366)	(99,793)	(130,531)
Amortization of capitalized software developed for sale	935	460	2,510	550
Depreciation and amortization	170,782	151,143	502,463	436,552
Interest expense	58,433	61,439	177,284	185,733
Equity compensation	24,807	10,944	74,718	34,858
Acquisition accounting adjustments	(4,864)	20,601	(7,077)	103,826
Acquisition and divestiture-related costs	8,707	2,661	28,867	10,119
Integration and related costs	5,894	9,688	23,195	27,581
Strategic initiatives, duplicative and transition costs	13,492	4,324	38,064	13,169
Severance costs	2,640	2,591	14,663	10,467
Accretion and changes in estimate, net	4,482	(2,759)	13,570	8,429
Impairment of long-lived assets and other	2,537	658	4,230	14,418
Loss on extinguishment of debt	1,653	6,145	3,885	7,634
Gain on sale of businesses		(32,217)		(60,487)
Contingent consideration				(3,000)
Other non-routine, net	4,628	112	12,149	2,801
Adjusted EBITDA	259,539	233,424	788,728	662,119
Postage and Eliminations [Member]
Segment Reporting Information [Line Items]
Net revenue	20,322	22,006	56,431	73,142
Purchase Accounting Adjustment [Member]
Segment Reporting Information [Line Items]
Net revenue		(24,179)	(7,740)	(118,088)
Software and Analytics [Member]
Segment Reporting Information [Line Items]
Net revenue	386,020	372,212	1,169,760	1,118,661
Adjusted EBITDA	125,131	120,779	397,814	382,103
Reconciliation of income (loss) before tax provision (benefit) to Adjusted EBITDA
Adjusted EBITDA	125,131	120,779	397,814	382,103
Network Solutions [Member]
Segment Reporting Information [Line Items]
Net revenue	226,963	192,588	652,023	519,509
Adjusted EBITDA	120,735	103,847	343,208	268,858
Reconciliation of income (loss) before tax provision (benefit) to Adjusted EBITDA
Adjusted EBITDA	120,735	103,847	343,208	268,858
Technology-Enabled Services [Member]
Segment Reporting Information [Line Items]
Net revenue	232,760	222,514	690,210	642,037
Adjusted EBITDA	13,673	8,798	47,706	11,158
Reconciliation of income (loss) before tax provision (benefit) to Adjusted EBITDA
Adjusted EBITDA	13,673	8,798	47,706	11,158
Postage [Member]
Segment Reporting Information [Line Items]
Net revenue	$ 54,917	$ 49,877	$ 158,675	$ 145,672

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Summary Of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	$ 3,244,166	$ 3,263,853	$ 3,252,228	$ 3,209,250	$ 3,239,354	$ 3,285,447
Balance	3,247,595	3,244,166	3,263,853	3,233,738	3,209,250	3,239,354
Foreign Currency Translation Adjustment [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	15,545	17,701	14,130	4,490	(731)	(7,084)
Change associated with foreign currency translation	3,693	(2,156)	3,571	11,526	5,221	6,353
Balance	19,238	15,545	17,701	16,016	4,490	(731)
Cash Flow Hedge [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	(2,749)	(2,790)	(2,909)	(6,468)	(4,472)	(288)
Change associated with current period hedging	3,887	(502)	(294)	(383)	(2,277)	(4,459)
Reclassification into earnings	708	543	413	302	281	275
Balance	1,846	(2,749)	(2,790)	(6,549)	(6,468)	(4,472)
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	12,796	14,911	11,221	(1,978)	(5,203)	(7,372)
Change associated with foreign currency translation	3,693	(2,156)	3,571	11,526	5,221	6,353
Change associated with current period hedging	3,887	(502)	(294)	(383)	(2,277)	(4,459)
Reclassification into earnings	708	543	413	302	281	275
Balance	$ 21,084	$ 12,796	$ 14,911	$ 9,467	$ (1,978)	$ (5,203)